ALPS Advisors’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-93,705
| Closed | -$2.22M | – | 874 |
|
|
2019
Q3 | $2.22M | Buy |
93,705
+5,160
| +6% | +$122K | 0.02% | 204 |
|
|
2019
Q2 | $2.66M | Buy |
+88,545
| New | +$2.66M | 0.02% | 200 |
|
|
2018
Q4 | – | Sell |
-57,230
| Closed | -$1.04M | – | 986 |
|
|
2018
Q3 | $1.04M | Buy |
57,230
+10,377
| +22% | +$188K | 0.01% | 387 |
|
|
2018
Q2 | $466K | Buy |
46,853
+5,241
| +13% | +$52.1K | ﹤0.01% | 656 |
|
|
2018
Q1 | $221K | Buy |
41,612
+16,539
| +66% | +$87.8K | ﹤0.01% | 832 |
|
|
2017
Q4 | $213K | Buy |
25,073
+2,806
| +13% | +$23.8K | ﹤0.01% | 806 |
|
|
2017
Q3 | $325K | Buy |
22,267
+1,897
| +9% | +$27.7K | ﹤0.01% | 722 |
|
|
2017
Q2 | $382K | Buy |
+20,370
| New | +$382K | ﹤0.01% | 690 |
|